lt;table border=0 width= valign=top cellpadding=2 cellspacing=7gt;lt;trgt;lt;td valign=top class=jgt;lt;font style=quot;font-size:85%;font-family:arial,sans-serifquot;gt;lt;brgt;lt;div style=quot;padding-top:0.8em;quot;gt;lt;img alt=quot;quot; height=quot;1quot; width=quot;1quot;gt;lt;/divgt;lt;div class=lhgt;lt;a href=quot;http://news.google.com/news/url?sa=Tct=us/0-0fd=Rurl=http://www.marketwatch.com/news/story/Competitive-Technologies-Submit-Compliance-Plan/story.aspx%3Fguid%3D%257BF1C75DF3-7005-4A7E-A957-582B44A7A98F%257Dcid=1277508692ei=whE4SYjeGZ3CwAHznMygDwusg=AFQjCNE1JMJHO16W1T4ZiFREh6cAiltOTAquot;gt;Competitive Technologies to lt;bgt;Submitlt;/bgt; Compliance Plan to NYSE Alternextlt;/agt;lt;brgt;lt;font size=-1gt;lt;font color=#6f6f6fgt;MarketWatchnbsp;-lt;/fontgt; lt;nobrgt;1 hour agolt;/nobrgt;lt;/fontgt;lt;brgt;lt;font size=-1gt;CTT will lt;bgt;submitlt;/bgt; such a plan. In the meantime, the stock continues to trade at NYSE Alternext US. CTT was notified on December 2, 2008 that it had fallen lt;bgt;...lt;/bgt;lt;/fontgt;lt;/divgt;lt;/fontgt;lt;/tdgt;lt;/trgt;lt;/tablegt;
lt;table border=0 width= valign=top cellpadding=2 cellspacing=7gt;lt;trgt;lt;td valign=top class=jgt;lt;font style=quot;font-size:85%;font-family:arial,sans-serifquot;gt;lt;brgt;lt;div style=quot;padding-top:0.8em;quot;gt;lt;img alt=quot;quot; height=quot;1quot; width=quot;1quot;gt;lt;/divgt;lt;div class=lhgt;lt;a href=quot;http://news.google.com/news/url?sa=Tct=us/2-0fd=Rurl=http://www.reuters.com/article/marketsNews/idUSL446342220081204cid=1277370896ei=whE4SYjeGZ3CwAHznMygDwusg=AFQjCNEtYNsA1gK27rVKVy5xALEq1SARIQquot;gt;UPDATE 1-Roche to lt;bgt;submitlt;/bgt; response to FDA on Actemra Q3 2009lt;/agt;lt;brgt;lt;font size=-1gt;lt;font color=#6f6f6fgt;Reutersnbsp;-lt;/fontgt; lt;nobrgt;10 hours agolt;/nobrgt;lt;/fontgt;lt;brgt;lt;font size=-1gt;VX: Quote, Profile, Research, Stock Buzz) will lt;bgt;submitlt;/bgt; information on its rheumatoid arthritis drug Actemra that the US Food and Drug Administration has lt;bgt;...lt;/bgt;lt;/fontgt;lt;brgt;lt;font size=-1gt;lt;a href=quot;http://news.google.com/news/url?sa=Tct=us/2-1fd=Rurl=http://money.cnn.com/news/newsfeeds/articles/djf500/200812040848DOWJONESDJONLINE000638_FORTUNE5.htmcid=1277370896ei=whE4SYjeGZ3CwAHznMygDwusg=AFQjCNGlKcmfu9rEB6cdR8LWEiX3Vm5ucQquot;gt;2nd UPDATE: FDA Asks Roche For More Data On Key Drug Actemralt;/agt; lt;font size=-1 color=#6f6f6fgt;lt;nobrgt;CNNMoney.comlt;/nobrgt;lt;/fontgt;lt;/fontgt;lt;brgt;lt;font size=-1gt;lt;a href=quot;http://news.google.com/news/url?sa=Tct=us/2-2fd=Rurl=http://www.tradingmarkets.com/.site/news/Stock%2520News/2065031/cid=1277370896ei=whE4SYjeGZ3CwAHznMygDwusg=AFQjCNFFyBHeFSetoWHfJzai9axWEXgbPAquot;gt;UPDATE 1-Roche to lt;bgt;submitlt;/bgt; response to FDA on Actemra Q3 2009lt;/agt; lt;font size=-1 color=#6f6f6fgt;lt;nobrgt;Trading Markets (press release)lt;/nobrgt;lt;/fontgt;lt;/fontgt;lt;brgt;lt;font size=-1gt;lt;a href=quot;http://news.google.com/news/url?sa=Tct=us/2-3fd=Rurl=http://www.reuters.com/article/governmentFilingsNews/idUSL446342220081204cid=1277370896ei=whE4SYjeGZ3CwAHznMygDwusg=AFQjCNGTM15VqgL6CL_i1e756e3Q3UVE2Qquot;gt;UPDATE 2-US FDA seeks more data on Roche arthritis druglt;/agt; lt;font size=-1 color=#6f6f6fgt;lt;nobrgt;Reuterslt;/nobrgt;lt;/fontgt;lt;/fontgt;lt;brgt;lt;font class=p size=-1gt;lt;a class=p href=http://news.google.com/news?hl=enned=usie=UTF-8ncl=1277370896gt;lt;nobrgt;all 30 news articleslt;/nobrgt;lt;/agt;lt;/fontgt;lt;/divgt;lt;/fontgt;lt;/tdgt;lt;/trgt;lt;/tablegt;
If you liked our web site or if you know someone that might be interested in our web site please use this form to let them know about it!
Please contribute to the growth of our web site!